AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0086
-0.0001 (-1.15%)
Jun 20, 2024, 11:14 AM EDT - Market open

AXIM Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018 - 2012
Market Capitalization
345574823
Upgrade
Market Cap Growth
--5.61%-91.95%19.21%111.31%-47.37%
Upgrade
Enterprise Value
91010635428
Upgrade
PE Ratio
-2.57-0.54-0.77-3.45-7.10-3.34
Upgrade
PS Ratio
29.37109.47516.45942.06-28.28
Upgrade
PB Ratio
-0.40-0.57-0.95-24.3630.51-3.34
Upgrade
P/FCF Ratio
-1.53-4.20-2.23-22.45-14.42-4.50
Upgrade
P/OCF Ratio
-1.54-4.20-2.24-22.90-14.86-4.50
Upgrade
EV/Sales Ratio
102.88248.701149.401045.70-35.28
Upgrade
EV/EBITDA Ratio
-4.60-4.23-2.41-10.77-11.13-4.34
Upgrade
EV/EBIT Ratio
-3.80-3.57-2.19-7.92-11.10-4.34
Upgrade
EV/FCF Ratio
-4.74-9.54-4.97-24.92-16.19-5.62
Upgrade
Debt / Equity Ratio
-0.84-0.72-1.17-2.874.03-0.90
Upgrade
Debt / EBITDA Ratio
-3.16-2.43-1.34-1.14-1.31-0.94
Upgrade
Debt / FCF Ratio
-3.25-5.49-2.76-2.65-1.90-1.22
Upgrade
Quick Ratio
0.020.030.010.180.310.32
Upgrade
Current Ratio
0.020.030.030.250.480.48
Upgrade
Asset Turnover
0.020.010.000.0100.47
Upgrade
Interest Coverage
-1.81-2.28-2.48-16.44-15.43-20.08
Upgrade
Return on Equity (ROE)
75.24%105.60%123.45%706.45%-429.85%100.16%
Upgrade
Return on Assets (ROA)
-141.35%-194.40%-141.43%-310.29%-59.49%-400.23%
Upgrade
Return on Capital (ROIC)
230.98%139.37%-554.34%-182.27%-62.84%990.80%
Upgrade
Earnings Yield
-222.99%-186.30%-129.97%-29.00%-14.09%-29.95%
Upgrade
FCF Yield
-78.13%-23.82%-44.79%-4.45%-6.93%-22.20%
Upgrade
Buyback Yield / Dilution
-21.87%-37.60%-25.79%-19.16%-78.19%-8.14%
Upgrade
Total Shareholder Return
-21.87%-37.60%-25.79%-19.16%-78.19%-8.14%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.